Australian pharmaceutical distributor spanning generics, biologics, and OTC medicines
Arrotex is Australia's largest pharmaceutical provider, operating across generics, biologics, biosimilars, and OTC channels. The tech stack reveals a hybrid enterprise architecture: Microsoft ecosystem (Dynamics 365, Azure, Synapse, Fabric) for core ERP and data warehousing, paired with modern data tools (Databricks, Spark, Python) and Salesforce for go-to-market. Active hiring across sales, marketing, and product—with senior and manager roles leading—signals expansion in demand planning, forecasting, and omnichannel strategy; this matches stated pain points around S&OP optimization, trade spend management, and new product adoption.
Arrotex Pharmaceuticals is Australia's largest pharmaceutical provider, serving health providers, physicians, pharmacies, government, and patients across a broad portfolio: prescription medicines, generics, biologics, biosimilars, OTC medicines, and antibiotics. Based in Cremorne, Victoria, the company operates as part of DBG Health. The organization spans 201–500 employees and is currently scaling sales, marketing, product, and operations teams. Core operational challenges include forecasting accuracy, profitability optimization, and coordination of product launches across regional markets.
Arrotex runs Microsoft Dynamics 365 (ERP), Azure cloud infrastructure (Synapse, Data Lake, SQL Database), Databricks and Apache Spark for analytics, Salesforce for commercial operations, Workday for HR, and NetSuite for financial management.
Active projects include omnichannel go-to-market strategy, demand planning capability development, S&OP demand reviews, sales forecasting optimization, product launch coordination, and oncology portfolio strategy.
Arrotex Pharmaceuticals's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.